bioactive spinal solutions Archives

Posted August 20, 2019

FDA 510(K) Clearance of its EVOL-SI Joint Fusion System

The commercialization of the EVOL-SI system addresses the needs of orthopedic surgeons and neurosurgeons seeking superior clinical outcomes following sacral-iliac surgery. Waxhaw, NC August 20, [...]

FDA 510(K) Clearance of its New HA Enhanced PEEK Interbody for the Cervical Spine, the EVOL ha-C

Cutting Edge Spine, a US leader in the development and commercialization of bio-active technologies for the spine, today announced the 510(k) clearance and commercial launch of it’s latest [...]

the EVOS System and FDA 510(k) Clearance

Cutting Edge Spine, a technology driven developer and marketer of highly differentiated implant systems, announced that the US Food and Drug Administration has cleared the EVOS-ha, a [...]